Analyzing the correlation between S100A2 mRNA expression and ccRCC stage in the TCGA dataset via GEPIA 2 website indicated an upregulation of S100A2 at the advanced tumor stage (Fig. 1C) [22]. This evidence concerns the gene S100A2 and nonpapillary renal cell carcinoma.